The information collected included author(s) and year of publication, study design, sample size, participant characteristics (age, sex), intervention details (type of SGLT2 inhibitor, dosage), comparison group details (placebo or other diabetes medications), outcomes measured (weight, BMI, body composition), and key findings and conclusions. Here, SLC5A2 is linked to diabetes mellitus.